Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Chamorey

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Pharmacogenomics|August 12, 2009
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancerJean-Louis Formento, Marie-Christine Etienne-Grimaldi, Mireille Francoual, et al.
JCO Clinical Cancer Informatics|August 12, 2022
RUBY: Natural Language Processing of French Electronic Medical Records for Breast Cancer ResearchRenaud Schiappa, Sara Contu, Dorian Culie, et al.
Oncotarget|June 23, 2016
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinomaYordan Benhamou, Vincent Picco, Hélène Raybaud, et al.
Brachytherapy|July 13, 2017
Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapyShakeel Sumodhee, Johan Levy, Emmanuel Chamorey, et al.
Cancer Reports (Hoboken, N.J.)|June 22, 2021
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECTJoël Guigay, Emmanuel Chamorey, Gautier Lefebvre, et al.
JCO Clinical Cancer Informatics|May 26, 2023
Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record SystemRenaud Schiappa, Sara Contu, Dorian Culie, et al.
Journal of Clinical Medicine|February 11, 2023
Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional OutcomesPierre Mattei, Jocelyn Gal, Emmanuel Chamorey, et al.
Midwifery|June 6, 2026
Predictive models for estimating the duration of labour induction: A systematic review and critical appraisalToni Gouazé, Alexandra Musso, Jérôme Delotte, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumorsPierre-Yves Bondiau, Phillipe Bahadoran, Michel Lallement, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2017
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapyLaura Lattanzio, Nerina Denaro, Daniela Vivenza, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Pharmacogenomics|August 12, 2009
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancerJean-Louis Formento, Marie-Christine Etienne-Grimaldi, Mireille Francoual, et al.
JCO Clinical Cancer Informatics|August 12, 2022
RUBY: Natural Language Processing of French Electronic Medical Records for Breast Cancer ResearchRenaud Schiappa, Sara Contu, Dorian Culie, et al.
Oncotarget|June 23, 2016
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinomaYordan Benhamou, Vincent Picco, Hélène Raybaud, et al.
Brachytherapy|July 13, 2017
Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapyShakeel Sumodhee, Johan Levy, Emmanuel Chamorey, et al.
Cancer Reports (Hoboken, N.J.)|June 22, 2021
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECTJoël Guigay, Emmanuel Chamorey, Gautier Lefebvre, et al.
JCO Clinical Cancer Informatics|May 26, 2023
Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record SystemRenaud Schiappa, Sara Contu, Dorian Culie, et al.
Journal of Clinical Medicine|February 11, 2023
Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional OutcomesPierre Mattei, Jocelyn Gal, Emmanuel Chamorey, et al.
Midwifery|June 6, 2026
Predictive models for estimating the duration of labour induction: A systematic review and critical appraisalToni Gouazé, Alexandra Musso, Jérôme Delotte, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumorsPierre-Yves Bondiau, Phillipe Bahadoran, Michel Lallement, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2017
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapyLaura Lattanzio, Nerina Denaro, Daniela Vivenza, et al.
Pageof 16